Dec 21, 2012, 09.00 AM | Source: PTI
French drug-maker Sanofi has entered into an agreement to acquire the animal health division of Indian firm Dosch Pharmaceuticals for an undisclosed amount.
Merial Chief Executive Officer Jose Barella. Barella added that combination of Dosch's animal health brands and distribution strength, along with the robust new product pipelines from both Merial and Dosch, will strongly position Merial to become rapidly a major animal health player in India.
Mumbai-headquartered Dosch Pharmaceuticals is a diversified pharmaceutical company, primarily operating through two divisions, animal health and exports. "The animal health division being acquired by Merial has more than 86 products under 50 brands for ruminants, poultry and companion animals," the statement said.
Products include an extensive range of animal health therapeutics and nutritional feed supplements. Within the animal health division, Dosch has a 279 member sales force, covering 18 Indian states.
"The strong nationwide sales, marketing and distribution network of Dosch, along with established products and people will be an ideal platform for Merial to enter the fast developing animal health market of India," Dosch Chairman and Managing Director Sanjay Doshi said.
Dosch CEO Sharat Tugnait and his management team will manage the future combined operations of Dosch and Merial in India under the supervision of Merila's Mayank Parekh, the company said.
The animal health market in India is estimated at more than Euro 350 million in 2012, and is experiencing annual double digit growth. India is home to the world's largest herd of cattle and buffalo, second largest herd of sheep and goats, and has the world's fifth largest population of poultry. The country is also the world's largest milk producer.
Pharma sector hiring likely to see 20% growth in 2016: Report
The pharma and healthcare sector is looking at an
Prefer Alembic Pharma: Mehraboon Irani
Mehraboon Irani of Nirmal Bang Securities is of th
Prefer pharma, Alembic Pharma looks interesting: Dipan Mehta
Dipan Mehta, Member at BSE & NSE is of the view th
'Pharma cos to see muted exports, stable revenues in FY17'
The overall pharmaceutical exports are expected to
Look at Cadila Healthcare, Dishman Pharma: Jai Bala
Jai Bala of Cashthechaos.com is of the view that o
BFSI, retail, pharma to be impacted most by Ind AS: Survey